PMID: 9638514Jan 1, 1997Paper

Lipoproteins and cardiovascular risk-from genetics to CHD prevention

Journal of Atherosclerosis and Thrombosis
P CullenG Assmann

Abstract

Dyslipidemia is said to be present when lipid or lipoprotein levels lie within a range which is known from epidemiological studies to be associated with secondary complications, in particular atherosclerosis of the coronary arteries, or when a lipid or lipoprotein grossly deviates from the norm as in abetalipoproteinemia, hypobetalipoproteinemia or the HDL deficiency syndromes. In most cases, dyslipidemia is due not to a single genetic or environmental factor, but to a combination of the effects of several genes of small effect (polygenes) and environment. In other cases, however, dyslipidemia is caused by a mutation in a single gene of large effect. In such cases, the extent and nature of the phenotype depends primarily on the identity of the gene involved, but is also modulated to an important degree by the nature of the mutation and the genetic and environmental background against which this mutation occurs. In addition, many cases of hyperlipidemia are secondary to other disorders such as hypothyroidism or renal dysfunction. Such disorders may also unmask or exacerbate a genetic lipoprotein disorder. Examples of the latter are the unmasking of type III hyperlipidemia by diabetes mellitus or the exacerbation of familial hype...Continue Reading

References

Dec 5, 1992·Lancet·J A HeadyM F Oliver
Jun 11, 1992·Journal of Clinical Epidemiology·T HarrisA G Schatzkin
Dec 19, 1990·JAMA : the Journal of the American Medical Association·J P KaneR J Havel
Apr 8, 1989·BMJ : British Medical Journal·C G IslesA F Lever
Jun 1, 1989·British Journal of Cancer·N J WaldA Bailey
Feb 9, 1985·British Medical Journal·C E SalmondI A Prior
Mar 8, 1980·Lancet·G Rose, M J Shipley
May 22, 1981·JAMA : the Journal of the American Medical Association·B PetersonN H Sternby
Jul 1, 1981·American Journal of Epidemiology·A KaganA Nomura
Jul 1, 1981·American Journal of Epidemiology·M R Garcia-PalmieriR J Havlik
Jan 16, 1981·JAMA : the Journal of the American Medical Association·R R WilliamsT R Dawber
May 1, 1993·American Journal of Epidemiology·A J SchuitF J Kok
Jun 1, 1996·The American Journal of Cardiology·G AssmannA von Eckardstein

❮ Previous
Next ❯

Citations

Jun 11, 2008·Journal of Human Genetics·Yongjun LiuDonna K Arnett
Sep 15, 2004·American Journal of Ophthalmology·Christopher A GirkinRobert N Weinreb
Sep 5, 2003·Journal of Human Genetics·Shuji OnoYasushi Saito
Jan 5, 2008·Journal of Atherosclerosis and Thrombosis·Akiko MiiYasuo Katayama
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Current Atherosclerosis Reports
D J Rader, U J Tietge
Nihon rinsho. Japanese journal of clinical medicine
T Murayama
Journal of the National Medical Association
Didem SenTomris Erbas
© 2022 Meta ULC. All rights reserved